Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.
The item "Other-Stockholder-Equity" stands at 4.29 Trillion Japanese Yens as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Other Stockholder Equity" stands at 4.29 Trillion JPY. This represents an increase of 157.41 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 2.58 Trillion Japanese Yens compared to the value the year prior.
The 1 year change is 2.58 Trillion Japanese Yens.
The 3 year change is 2.70 Trillion Japanese Yens.
The 5 year change is 2.68 Trillion Japanese Yens.
The 10 year change is 4.26 Trillion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Stockholder Equity | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Stockholder Equity | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Stockholder Equity | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Stockholder Equity | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Stockholder Equity | 280,205,508,085.11 |